Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Evidence summary: Experiences of people with disabilities during COVID19 in Asia and the Pacific

CBM , Nossal Institute for Global Health . 2021;
Download PDF
Publication

Enhanced IL-6 and IL-12B Gene Expression After SARS-CoV-2 Infection in Leprosy Patients May Increase the Risk of Neural Damage.

Junior G, Kurizky P, Cerqueira S, et al. The American journal of tropical medicine and hygiene. 2021;
Download PDF
Publication

Validation of the Brazilian version of the WHODAS 2.0 for people affected by leprosy

de Sousa Almondes JG, de Castro SS, Nogueira P, et al. Lepra. Leprosy Review. 2021; 92 (1) : 47-58.
Download PDF
Publication

Physical disabilities caused by leprosy in 100 million cohort in Brazil.

Sanchez MN, Nery J, Pescarini J, et al. BMC infectious diseases. 2021; 21 (1) : 290.
Download PDF
Publication

e-Learning Modules on Leprosy

WHO South-East Asia Regional Office . 2021;
Download PDF
Publication

Leprosy and lymphatic filariasis comorbidity: the case for an integrated functional limitation grading system

Rawson T, Ranganadha Rao P. Lepra. Leprosy Review. 2014; 85 (1) : 63-67.
Download PDF
Publication

Quality of life and mental health status of hansen disease patients, attending a designated leprosy care center in South-India.

Patil A, Mayur S. International journal of mycobacteriology. 2021; 10 (1) : 31-36.
Download PDF
Publication

Magnitude and temporal trends of leprosy relapse in the state of Ceará, Brazil in the period 2001-2018.

Nzundu Boigny R, Florêncio CMGD, Cavalcante K, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2021;
Download PDF
Publication

Revised estimates of leprosy disability weights for assessing the global burden of disease: A systematic review and individual patient data meta-analysis.

Chandran S, Tiwari A, Lustosa A, et al. PLoS neglected tropical diseases. 2021; 15 (3) : e0009209.
Download PDF
Publication

Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease

Pan American Health Organization . 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 40
  • Next page ››
Subscribe to Disability

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD